Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2013-12-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Manual screw type (Monarch III), Manual plunger type (Royale) and motorised injector (Autosert). Further, the investigators also looked at incision integrity by comparing ingress of trypan blue from the ocular surface into the anterior chamber.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Investigation of Corneal Incision Size After Intraocular Lens (IOL) Implantation
NCT02826421
Surgical Outcomes After Routine Cataract Extraction & Implantation of a Conventional or Spheric Intraocular Lens
NCT00366496
Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+
NCT06574646
Patient Satisfaction and Visual Function Following Implantation of Trifocals or Extended Range of Vision Intraocular Lenses
NCT04900662
A Comparison of Aspheric Toric Intraocular Lens (IOL) Implantation Versus Aspheric Non-Toric Lens Implantation
NCT01225926
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Manual, screw type injector (Monarch III)
2. Manual, plunger type injector (Royale, ASICO)
3. Motorized injector (Autosert, Alcon)
Having performed a phacoemulsification through 2.2mm incision, IOL implantation was performed using a D cartridge and one of three injectors which was decided in a randomized fashion.
The investigators evaluated incision enlargement at following points : at the end of phacoemulsification, and then, at the end of IOL implantation The investigators also looked at trypan blue ingress into the anterior chamber from the ocular surface. At 1 day, 1 week, and 1 month after surgery anterior segment OCT morphology was also studied.
further, the surgeon was asked to subjectively grade the ease of implantation with each injector
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autosert Group
Procedure / Surgery : Intraocular lens implantation with Autosert injector
Intraocular lens implantation
Intraocular lens implantation
Autosert Injector
Motorised injection device for intraocular lens implantation
Royale Group
Procedure / Surgery : Intraocular lens implantation with Royale Injector
Intraocular lens implantation
Intraocular lens implantation
Royale Injector
Manual, plunger type injection device for intraocular lens implantation
Monarch III Injector
Procedure / Surgery : Intraocular lens implantation with Monarch III group
Monarch III Injector
Manual, screw type injection device for intraocular lens implantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraocular lens implantation
Intraocular lens implantation
Autosert Injector
Motorised injection device for intraocular lens implantation
Royale Injector
Manual, plunger type injection device for intraocular lens implantation
Monarch III Injector
Manual, screw type injection device for intraocular lens implantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Nuclear or corticonuclear of grade 2 to 4 according to the Lens Opacities Classification System (LOCS III)
Exclusion Criteria
* uveitis,
* shallow anterior chamber (depth \<2.1mm),
* prior ocular trauma or surgery,
* maximal pupillary dilatation \<6mm,
* high myopia (axial length \>25mm),
* posterior polar cataracts,
* dense cataracts, and
* an IOL power \<19.0 D or \>25.0 D
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iladevi Cataract and IOL Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abhay R. Vasavada
M.S., F.R.C.S (England)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
abhay r vasavada, ms, frcs
Role: PRINCIPAL_INVESTIGATOR
iladevi cataract & iol research centre
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.